Share Price and Basic Stock Data
Last Updated: February 12, 2026, 8:33 pm
| PEG Ratio | 3.37 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Coromandel International Ltd, a prominent player in the fertiliser industry, reported a share price of ₹2,269 and a market capitalization of ₹67,096 Cr. The company’s revenue from operations stood at ₹29,628 Cr for the fiscal year ending March 2023, reflecting a notable increase from ₹19,111 Cr in the previous year. However, the revenue is projected to decline to ₹22,058 Cr in March 2024 before recovering to ₹24,085 Cr by March 2025. This fluctuation in revenue indicates sensitivity to market conditions and demand for fertilisers, which is influenced by agricultural productivity and government policies. The company reported quarterly sales that peaked at ₹9,654 Cr in September 2025, showcasing its capacity to generate substantial revenue during peak agricultural seasons. Coromandel’s ability to maintain a steady revenue stream amid varying market conditions demonstrates its strong market position and operational efficiency.
Profitability and Efficiency Metrics
Coromandel International’s profitability metrics reveal a robust operating profit margin (OPM) of 9% for the latest fiscal year. The operating profit stood at ₹2,902 Cr for March 2023, declining to ₹2,380 Cr in March 2024, before recovering to ₹2,577 Cr in March 2025. The company’s net profit for the same fiscal year was ₹2,013 Cr, with an earnings per share (EPS) of ₹68.46. Notably, the return on equity (ROE) was reported at 16.9%, while return on capital employed (ROCE) was a healthy 23.2%, indicating effective use of equity and capital. Coromandel’s interest coverage ratio (ICR) of 11.38x suggests strong capacity to meet interest obligations, reflecting financial stability. However, the OPM has shown variability across quarters, with a high of 15% in September 2023 and a low of 6% in December 2023, indicating potential challenges in managing costs and pricing strategies.
Balance Sheet Strength and Financial Ratios
The balance sheet of Coromandel International demonstrates significant strength, with total assets reported at ₹18,917 Cr as of March 2025. The company has maintained a conservative borrowing approach, with total borrowings at ₹1,471 Cr, resulting in a low debt-to-equity ratio of 0.02, indicating minimal financial leverage. Reserves have steadily increased to ₹12,149 Cr, providing a strong cushion for future growth and expansion. The price-to-book value (P/BV) ratio stood at 5.26x, suggesting that the stock is trading at a premium relative to its book value, which may reflect investor confidence in its growth prospects. Furthermore, the current ratio of 1.89 indicates adequate liquidity to cover short-term liabilities. However, the inventory turnover ratio of 5.13x is lower than typical sector averages, suggesting potential inefficiencies in inventory management.
Shareholding Pattern and Investor Confidence
Coromandel International’s shareholding pattern reveals a stable ownership structure, with promoter holding at 56.88%. Foreign institutional investors (FIIs) increased their stake to 14.45%, reflecting growing confidence among international investors. Domestic institutional investors (DIIs) hold 15.88%, while the public holds 12.70%, indicating a balanced distribution of ownership. Over the past few quarters, promoter holding has slightly declined from 57.41% in December 2022, suggesting a gradual dilution of control. The number of shareholders stood at 143,977, indicating a broad base of retail and institutional investors. This diversified ownership could enhance liquidity and market stability. However, the declining promoter share could raise concerns regarding long-term commitment, potentially impacting investor sentiment.
Outlook, Risks, and Final Insight
The outlook for Coromandel International remains cautiously optimistic, bolstered by its strong market position and financial metrics. However, the company faces several risks, including fluctuations in raw material prices, regulatory changes, and agricultural demand variability, which could impact profitability. The recent decline in sales for the upcoming quarters raises concerns about demand sustainability. Nonetheless, Coromandel’s robust operational efficiency and financial health provide a solid foundation for navigating these challenges. As the company continues to innovate and adapt to market conditions, its ability to sustain growth will depend on effective cost management and strategic investments. In scenarios where agricultural demand strengthens or if the company successfully implements operational improvements, Coromandel could enhance its profitability and market share significantly.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat State Fertilizers & Chemicals Ltd | 7,071 Cr. | 178 | 221/156 | 10.2 | 313 | 2.82 % | 6.18 % | 4.77 % | 2.00 |
| Bharat Agri Fert & Realty Ltd | 133 Cr. | 25.1 | 62.0/23.0 | 9.97 | 0.00 % | 6.14 % | 14.8 % | 1.00 | |
| Basant Agro Tech (India) Ltd | 101 Cr. | 11.1 | 17.9/9.27 | 17.1 | 20.0 | 0.45 % | 6.52 % | 2.36 % | 1.00 |
| Zuari Agro Chemicals Ltd | 1,015 Cr. | 241 | 395/155 | 3.06 | 602 | 0.00 % | 12.7 % | 9.06 % | 10.0 |
| Southern Petrochemicals Industries Corporation Ltd (SPIC) | 1,444 Cr. | 70.8 | 128/68.5 | 7.77 | 63.8 | 2.83 % | 16.9 % | 13.8 % | 10.0 |
| Industry Average | 10,232.81 Cr | 376.76 | 200.25 | 185.72 | 1.01% | 13.03% | 10.58% | 6.96 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8,310 | 5,476 | 5,693 | 6,988 | 5,464 | 3,913 | 4,729 | 7,433 | 6,935 | 4,988 | 7,042 | 9,654 | 8,779 |
| Expenses | 7,539 | 5,089 | 4,988 | 5,933 | 5,115 | 3,650 | 4,238 | 6,471 | 6,222 | 4,579 | 6,260 | 8,508 | 7,980 |
| Operating Profit | 771 | 387 | 706 | 1,055 | 349 | 263 | 490 | 962 | 713 | 409 | 782 | 1,147 | 800 |
| OPM % | 9% | 7% | 12% | 15% | 6% | 7% | 10% | 13% | 10% | 8% | 11% | 12% | 9% |
| Other Income | 40 | 47 | 44 | 45 | 59 | 84 | 54 | 65 | 114 | 473 | 84 | 116 | 83 |
| Interest | 57 | 52 | 41 | 46 | 38 | 62 | 57 | 66 | 73 | 66 | 68 | 102 | 84 |
| Depreciation | 47 | 45 | 48 | 54 | 64 | 63 | 65 | 69 | 71 | 85 | 121 | 102 | 147 |
| Profit before tax | 706 | 337 | 661 | 1,000 | 306 | 222 | 422 | 892 | 683 | 731 | 677 | 1,059 | 653 |
| Tax % | 25% | 27% | 25% | 25% | 25% | 26% | 27% | 26% | 26% | 21% | 26% | 25% | 25% |
| Net Profit | 527 | 246 | 494 | 755 | 228 | 164 | 309 | 659 | 508 | 578 | 502 | 793 | 488 |
| EPS in Rs | 17.92 | 8.38 | 16.80 | 25.71 | 7.85 | 5.45 | 10.56 | 22.55 | 17.37 | 19.67 | 17.13 | 27.31 | 17.15 |
Last Updated: February 6, 2026, 6:46 am
Below is a detailed analysis of the quarterly data for Coromandel International Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 8,779.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9,654.00 Cr. (Sep 2025) to 8,779.00 Cr., marking a decrease of 875.00 Cr..
- For Expenses, as of Dec 2025, the value is 7,980.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 8,508.00 Cr. (Sep 2025) to 7,980.00 Cr., marking a decrease of 528.00 Cr..
- For Operating Profit, as of Dec 2025, the value is 800.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,147.00 Cr. (Sep 2025) to 800.00 Cr., marking a decrease of 347.00 Cr..
- For OPM %, as of Dec 2025, the value is 9.00%. The value appears to be declining and may need further review. It has decreased from 12.00% (Sep 2025) to 9.00%, marking a decrease of 3.00%.
- For Other Income, as of Dec 2025, the value is 83.00 Cr.. The value appears to be declining and may need further review. It has decreased from 116.00 Cr. (Sep 2025) to 83.00 Cr., marking a decrease of 33.00 Cr..
- For Interest, as of Dec 2025, the value is 84.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 102.00 Cr. (Sep 2025) to 84.00 Cr., marking a decrease of 18.00 Cr..
- For Depreciation, as of Dec 2025, the value is 147.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 102.00 Cr. (Sep 2025) to 147.00 Cr., marking an increase of 45.00 Cr..
- For Profit before tax, as of Dec 2025, the value is 653.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,059.00 Cr. (Sep 2025) to 653.00 Cr., marking a decrease of 406.00 Cr..
- For Tax %, as of Dec 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 25.00%.
- For Net Profit, as of Dec 2025, the value is 488.00 Cr.. The value appears to be declining and may need further review. It has decreased from 793.00 Cr. (Sep 2025) to 488.00 Cr., marking a decrease of 305.00 Cr..
- For EPS in Rs, as of Dec 2025, the value is 17.15. The value appears to be declining and may need further review. It has decreased from 27.31 (Sep 2025) to 17.15, marking a decrease of 10.16.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:29 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10,053 | 11,306 | 11,481 | 10,031 | 11,083 | 13,225 | 13,137 | 14,182 | 19,111 | 29,628 | 22,058 | 24,085 | 28,620 |
| Expenses | 9,246 | 10,450 | 10,712 | 9,048 | 9,822 | 11,775 | 11,400 | 12,193 | 16,954 | 26,726 | 19,678 | 21,508 | 25,569 |
| Operating Profit | 808 | 856 | 769 | 983 | 1,261 | 1,450 | 1,737 | 1,989 | 2,156 | 2,902 | 2,380 | 2,577 | 3,051 |
| OPM % | 8% | 8% | 7% | 10% | 11% | 11% | 13% | 14% | 11% | 10% | 11% | 11% | 11% |
| Other Income | 46 | 50 | 87 | 54 | 55 | 8 | 35 | 76 | 141 | 171 | 223 | 703 | 787 |
| Interest | 240 | 210 | 221 | 224 | 178 | 251 | 235 | 106 | 75 | 190 | 187 | 262 | 309 |
| Depreciation | 96 | 105 | 106 | 101 | 99 | 114 | 158 | 173 | 173 | 182 | 229 | 290 | 378 |
| Profit before tax | 517 | 592 | 529 | 712 | 1,038 | 1,093 | 1,379 | 1,786 | 2,050 | 2,701 | 2,188 | 2,728 | 3,151 |
| Tax % | 29% | 32% | 32% | 33% | 33% | 34% | 23% | 26% | 25% | 25% | 25% | 25% | |
| Net Profit | 365 | 402 | 357 | 477 | 691 | 720 | 1,065 | 1,329 | 1,528 | 2,013 | 1,641 | 2,055 | 2,381 |
| EPS in Rs | 12.59 | 13.80 | 12.27 | 16.35 | 23.64 | 24.63 | 36.36 | 45.30 | 52.08 | 68.46 | 55.78 | 70.14 | 81.48 |
| Dividend Payout % | 36% | 33% | 33% | 31% | 27% | 26% | 33% | 26% | 23% | 18% | 11% | 21% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 10.14% | -11.19% | 33.61% | 44.86% | 4.20% | 47.92% | 24.79% | 14.97% | 31.74% | -18.48% | 25.23% |
| Change in YoY Net Profit Growth (%) | 0.00% | -21.33% | 44.81% | 11.25% | -40.67% | 43.72% | -23.13% | -9.82% | 16.77% | -50.22% | 43.71% |
Coromandel International Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 13% |
| 3 Years: | 8% |
| TTM: | 25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 10% |
| 3 Years: | 4% |
| TTM: | 36% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 25% |
| 3 Years: | 31% |
| 1 Year: | 33% |
| Return on Equity | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 23% |
| 3 Years: | 21% |
| Last Year: | 17% |
Last Updated: September 5, 2025, 2:15 am
Balance Sheet
Last Updated: December 10, 2025, 2:33 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 28 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 |
| Reserves | 2,253 | 2,173 | 2,605 | 2,862 | 2,867 | 3,329 | 4,288 | 5,121 | 6,329 | 7,878 | 9,390 | 11,058 | 12,149 |
| Borrowings | 1,843 | 2,288 | 2,677 | 2,228 | 2,728 | 2,954 | 2,019 | 385 | 395 | 393 | 492 | 780 | 1,471 |
| Other Liabilities | 3,481 | 3,872 | 3,871 | 3,526 | 4,224 | 4,261 | 3,812 | 3,360 | 4,532 | 5,934 | 5,933 | 7,049 | 11,086 |
| Total Liabilities | 7,605 | 8,362 | 9,182 | 8,645 | 9,848 | 10,574 | 10,149 | 8,895 | 11,285 | 14,235 | 15,845 | 18,917 | 24,736 |
| Fixed Assets | 1,734 | 1,380 | 1,320 | 1,328 | 1,327 | 1,309 | 2,032 | 2,015 | 2,092 | 2,200 | 3,112 | 4,139 | 5,574 |
| CWIP | 74 | 46 | 42 | 22 | 48 | 191 | 65 | 90 | 141 | 399 | 235 | 396 | 938 |
| Investments | 342 | 352 | 477 | 388 | 221 | 201 | 211 | 214 | 243 | 287 | 854 | 1,031 | 3,079 |
| Other Assets | 5,455 | 6,583 | 7,343 | 6,907 | 8,252 | 8,873 | 7,840 | 6,576 | 8,809 | 11,348 | 11,644 | 13,351 | 15,144 |
| Total Assets | 7,605 | 8,362 | 9,182 | 8,645 | 9,848 | 10,574 | 10,149 | 8,895 | 11,285 | 14,235 | 15,845 | 18,917 | 24,736 |
Below is a detailed analysis of the balance sheet data for Coromandel International Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 29.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 29.00 Cr..
- For Reserves, as of Sep 2025, the value is 12,149.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,058.00 Cr. (Mar 2025) to 12,149.00 Cr., marking an increase of 1,091.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,471.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 780.00 Cr. (Mar 2025) to 1,471.00 Cr., marking an increase of 691.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 11,086.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7,049.00 Cr. (Mar 2025) to 11,086.00 Cr., marking an increase of 4,037.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 24,736.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 18,917.00 Cr. (Mar 2025) to 24,736.00 Cr., marking an increase of 5,819.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 5,574.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,139.00 Cr. (Mar 2025) to 5,574.00 Cr., marking an increase of 1,435.00 Cr..
- For CWIP, as of Sep 2025, the value is 938.00 Cr.. The value appears strong and on an upward trend. It has increased from 396.00 Cr. (Mar 2025) to 938.00 Cr., marking an increase of 542.00 Cr..
- For Investments, as of Sep 2025, the value is 3,079.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,031.00 Cr. (Mar 2025) to 3,079.00 Cr., marking an increase of 2,048.00 Cr..
- For Other Assets, as of Sep 2025, the value is 15,144.00 Cr.. The value appears strong and on an upward trend. It has increased from 13,351.00 Cr. (Mar 2025) to 15,144.00 Cr., marking an increase of 1,793.00 Cr..
- For Total Assets, as of Sep 2025, the value is 24,736.00 Cr.. The value appears strong and on an upward trend. It has increased from 18,917.00 Cr. (Mar 2025) to 24,736.00 Cr., marking an increase of 5,819.00 Cr..
Notably, the Reserves (12,149.00 Cr.) exceed the Borrowings (1,471.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 807.00 | 854.00 | 767.00 | 981.00 | -1.00 | -1.00 | -1.00 | -384.00 | -393.00 | -391.00 | -490.00 | -778.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 54 | 47 | 52 | 59 | 52 | 50 | 48 | 14 | 5 | 7 | 23 | 19 |
| Inventory Days | 86 | 96 | 98 | 88 | 109 | 127 | 109 | 98 | 94 | 69 | 102 | 98 |
| Days Payable | 132 | 131 | 135 | 150 | 162 | 147 | 135 | 110 | 100 | 83 | 117 | 123 |
| Cash Conversion Cycle | 7 | 12 | 15 | -3 | -2 | 30 | 22 | 2 | -1 | -7 | 8 | -7 |
| Working Capital Days | 4 | 11 | 24 | 40 | 27 | 42 | 65 | 64 | 41 | 37 | 44 | 28 |
| ROCE % | 16% | 19% | 15% | 18% | 23% | 23% | 26% | 32% | 35% | 38% | 26% | 23% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Kotak Midcap Fund | 5,728,809 | 2.14 | 1298.38 | N/A | N/A | N/A |
| HDFC Mid Cap Fund | 4,652,867 | 1.14 | 1054.53 | 4,413,689 | 2026-01-26 03:17:01 | 5.42% |
| Kotak Large & Midcap Fund | 3,250,001 | 2.45 | 736.58 | N/A | N/A | N/A |
| Axis Midcap Fund | 2,692,866 | 1.92 | 610.31 | 4,652,378 | 2025-12-08 05:46:03 | -42.12% |
| DSP Mid Cap Fund | 2,282,965 | 2.64 | 517.41 | 5,065,035 | 2025-12-08 05:46:03 | -54.93% |
| Sundaram Mid Cap Fund | 1,730,022 | 2.95 | 392.09 | 1,731,201 | 2026-01-25 06:27:19 | -0.07% |
| Kotak Flexicap Fund | 1,500,000 | 0.6 | 339.96 | N/A | N/A | N/A |
| Nippon India Growth Mid Cap Fund | 1,210,830 | 0.65 | 274.42 | N/A | N/A | N/A |
| HSBC Value Fund | 972,513 | 1.49 | 220.41 | N/A | N/A | N/A |
| DSP Large & Mid Cap Fund | 963,792 | 1.24 | 218.43 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 70.23 | 55.81 | 68.51 | 52.09 | 45.34 |
| Diluted EPS (Rs.) | 70.12 | 55.81 | 68.38 | 51.98 | 45.22 |
| Cash EPS (Rs.) | 81.42 | 64.39 | 75.49 | 57.83 | 51.02 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 376.37 | 320.88 | 268.97 | 216.64 | 175.55 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 376.37 | 320.88 | 268.97 | 216.64 | 175.55 |
| Revenue From Operations / Share (Rs.) | 817.56 | 749.27 | 1007.75 | 651.14 | 483.37 |
| PBDIT / Share (Rs.) | 101.39 | 89.34 | 105.35 | 78.16 | 70.19 |
| PBIT / Share (Rs.) | 91.54 | 81.57 | 99.16 | 72.28 | 64.29 |
| PBT / Share (Rs.) | 94.40 | 75.24 | 92.70 | 69.71 | 60.69 |
| Net Profit / Share (Rs.) | 71.56 | 56.63 | 69.30 | 51.95 | 45.12 |
| NP After MI And SOA / Share (Rs.) | 70.14 | 55.78 | 68.47 | 52.08 | 45.30 |
| PBDIT Margin (%) | 12.40 | 11.92 | 10.45 | 12.00 | 14.52 |
| PBIT Margin (%) | 11.19 | 10.88 | 9.83 | 11.10 | 13.30 |
| PBT Margin (%) | 11.54 | 10.04 | 9.19 | 10.70 | 12.55 |
| Net Profit Margin (%) | 8.75 | 7.55 | 6.87 | 7.97 | 9.33 |
| NP After MI And SOA Margin (%) | 8.57 | 7.44 | 6.79 | 7.99 | 9.37 |
| Return on Networth / Equity (%) | 18.63 | 17.43 | 25.45 | 24.03 | 25.80 |
| Return on Capital Employeed (%) | 22.59 | 24.04 | 34.79 | 31.11 | 33.71 |
| Return On Assets (%) | 10.91 | 10.35 | 14.14 | 13.54 | 14.94 |
| Long Term Debt / Equity (X) | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 1.39 | 1.47 | 2.32 | 1.90 | 1.48 |
| Current Ratio (X) | 1.89 | 2.07 | 1.75 | 1.87 | 1.98 |
| Quick Ratio (X) | 1.21 | 1.28 | 0.99 | 1.05 | 1.19 |
| Inventory Turnover Ratio (X) | 5.13 | 3.00 | 4.84 | 3.80 | 2.65 |
| Dividend Payout Ratio (NP) (%) | 17.08 | 10.75 | 17.51 | 23.03 | 39.70 |
| Dividend Payout Ratio (CP) (%) | 14.98 | 9.44 | 16.06 | 20.70 | 35.12 |
| Earning Retention Ratio (%) | 82.92 | 89.25 | 82.49 | 76.97 | 60.30 |
| Cash Earning Retention Ratio (%) | 85.02 | 90.56 | 83.94 | 79.30 | 64.88 |
| Interest Coverage Ratio (X) | 11.38 | 14.10 | 16.30 | 30.40 | 19.49 |
| Interest Coverage Ratio (Post Tax) (X) | 7.71 | 9.94 | 11.72 | 21.20 | 13.53 |
| Enterprise Value (Cr.) | 55161.09 | 28896.11 | 24436.79 | 21701.81 | 21993.08 |
| EV / Net Operating Revenue (X) | 2.29 | 1.31 | 0.82 | 1.14 | 1.55 |
| EV / EBITDA (X) | 18.47 | 10.99 | 7.89 | 9.46 | 10.68 |
| MarketCap / Net Operating Revenue (X) | 2.42 | 1.44 | 0.87 | 1.23 | 1.60 |
| Retention Ratios (%) | 82.91 | 89.24 | 82.48 | 76.96 | 60.29 |
| Price / BV (X) | 5.26 | 3.36 | 3.27 | 3.69 | 4.41 |
| Price / Net Operating Revenue (X) | 2.42 | 1.44 | 0.87 | 1.23 | 1.60 |
| EarningsYield | 0.03 | 0.05 | 0.07 | 0.06 | 0.05 |
After reviewing the key financial ratios for Coromandel International Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 70.23. This value is within the healthy range. It has increased from 55.81 (Mar 24) to 70.23, marking an increase of 14.42.
- For Diluted EPS (Rs.), as of Mar 25, the value is 70.12. This value is within the healthy range. It has increased from 55.81 (Mar 24) to 70.12, marking an increase of 14.31.
- For Cash EPS (Rs.), as of Mar 25, the value is 81.42. This value is within the healthy range. It has increased from 64.39 (Mar 24) to 81.42, marking an increase of 17.03.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 376.37. It has increased from 320.88 (Mar 24) to 376.37, marking an increase of 55.49.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 376.37. It has increased from 320.88 (Mar 24) to 376.37, marking an increase of 55.49.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 817.56. It has increased from 749.27 (Mar 24) to 817.56, marking an increase of 68.29.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 101.39. This value is within the healthy range. It has increased from 89.34 (Mar 24) to 101.39, marking an increase of 12.05.
- For PBIT / Share (Rs.), as of Mar 25, the value is 91.54. This value is within the healthy range. It has increased from 81.57 (Mar 24) to 91.54, marking an increase of 9.97.
- For PBT / Share (Rs.), as of Mar 25, the value is 94.40. This value is within the healthy range. It has increased from 75.24 (Mar 24) to 94.40, marking an increase of 19.16.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 71.56. This value is within the healthy range. It has increased from 56.63 (Mar 24) to 71.56, marking an increase of 14.93.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 70.14. This value is within the healthy range. It has increased from 55.78 (Mar 24) to 70.14, marking an increase of 14.36.
- For PBDIT Margin (%), as of Mar 25, the value is 12.40. This value is within the healthy range. It has increased from 11.92 (Mar 24) to 12.40, marking an increase of 0.48.
- For PBIT Margin (%), as of Mar 25, the value is 11.19. This value is within the healthy range. It has increased from 10.88 (Mar 24) to 11.19, marking an increase of 0.31.
- For PBT Margin (%), as of Mar 25, the value is 11.54. This value is within the healthy range. It has increased from 10.04 (Mar 24) to 11.54, marking an increase of 1.50.
- For Net Profit Margin (%), as of Mar 25, the value is 8.75. This value is within the healthy range. It has increased from 7.55 (Mar 24) to 8.75, marking an increase of 1.20.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.57. This value is within the healthy range. It has increased from 7.44 (Mar 24) to 8.57, marking an increase of 1.13.
- For Return on Networth / Equity (%), as of Mar 25, the value is 18.63. This value is within the healthy range. It has increased from 17.43 (Mar 24) to 18.63, marking an increase of 1.20.
- For Return on Capital Employeed (%), as of Mar 25, the value is 22.59. This value is within the healthy range. It has decreased from 24.04 (Mar 24) to 22.59, marking a decrease of 1.45.
- For Return On Assets (%), as of Mar 25, the value is 10.91. This value is within the healthy range. It has increased from 10.35 (Mar 24) to 10.91, marking an increase of 0.56.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.39. It has decreased from 1.47 (Mar 24) to 1.39, marking a decrease of 0.08.
- For Current Ratio (X), as of Mar 25, the value is 1.89. This value is within the healthy range. It has decreased from 2.07 (Mar 24) to 1.89, marking a decrease of 0.18.
- For Quick Ratio (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has decreased from 1.28 (Mar 24) to 1.21, marking a decrease of 0.07.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.13. This value is within the healthy range. It has increased from 3.00 (Mar 24) to 5.13, marking an increase of 2.13.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 17.08. This value is below the healthy minimum of 20. It has increased from 10.75 (Mar 24) to 17.08, marking an increase of 6.33.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 14.98. This value is below the healthy minimum of 20. It has increased from 9.44 (Mar 24) to 14.98, marking an increase of 5.54.
- For Earning Retention Ratio (%), as of Mar 25, the value is 82.92. This value exceeds the healthy maximum of 70. It has decreased from 89.25 (Mar 24) to 82.92, marking a decrease of 6.33.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 85.02. This value exceeds the healthy maximum of 70. It has decreased from 90.56 (Mar 24) to 85.02, marking a decrease of 5.54.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 11.38. This value is within the healthy range. It has decreased from 14.10 (Mar 24) to 11.38, marking a decrease of 2.72.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 7.71. This value is within the healthy range. It has decreased from 9.94 (Mar 24) to 7.71, marking a decrease of 2.23.
- For Enterprise Value (Cr.), as of Mar 25, the value is 55,161.09. It has increased from 28,896.11 (Mar 24) to 55,161.09, marking an increase of 26,264.98.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.29. This value is within the healthy range. It has increased from 1.31 (Mar 24) to 2.29, marking an increase of 0.98.
- For EV / EBITDA (X), as of Mar 25, the value is 18.47. This value exceeds the healthy maximum of 15. It has increased from 10.99 (Mar 24) to 18.47, marking an increase of 7.48.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.42. This value is within the healthy range. It has increased from 1.44 (Mar 24) to 2.42, marking an increase of 0.98.
- For Retention Ratios (%), as of Mar 25, the value is 82.91. This value exceeds the healthy maximum of 70. It has decreased from 89.24 (Mar 24) to 82.91, marking a decrease of 6.33.
- For Price / BV (X), as of Mar 25, the value is 5.26. This value exceeds the healthy maximum of 3. It has increased from 3.36 (Mar 24) to 5.26, marking an increase of 1.90.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.42. This value is within the healthy range. It has increased from 1.44 (Mar 24) to 2.42, marking an increase of 0.98.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 24) to 0.03, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Coromandel International Ltd:
- Net Profit Margin: 8.75%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 22.59% (Industry Average ROCE: 13.03%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.63% (Industry Average ROE: 10.58%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 7.71
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.21
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 31.6 (Industry average Stock P/E: 200.25)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.02
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8.75%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Fertilisers | Coromandel House, Secunderabad Telangana 500003 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. A Vellayan | Chairman Emeritus |
| Mr. Arun Alagappan | Executive Chairman |
| Mr. Natrajan Srinivasan | Executive Vice Chairman |
| Mr. S Sankarasubramanian | Managing Director & CEO |
| Dr. Raghuram Devarakonda | Executive Director |
| Mr. Arunachalam Vellayan | Whole Time Director |
| Mr. Narayanan Vellayan | Whole Time Director |
| Mr. Sudarshan Venu | Independent Director |
| Dr. Deepali Pant Joshi | Independent Director |
| Mr. Adnan Ahmad | Independent Director |
| Mr. Aditya Himatsingka | Independent Director |
| Mr. Suresh Subramanian | Independent Director |
| Mr. Durgashankar Subramaniam | Independent Director |
FAQ
What is the intrinsic value of Coromandel International Ltd?
Coromandel International Ltd's intrinsic value (as of 13 February 2026) is ₹1939.93 which is 14.54% lower the current market price of ₹2,270.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹66,998 Cr. market cap, FY2025-2026 high/low of ₹2,720/1,590, reserves of ₹12,149 Cr, and liabilities of ₹24,736 Cr.
What is the Market Cap of Coromandel International Ltd?
The Market Cap of Coromandel International Ltd is 66,998 Cr..
What is the current Stock Price of Coromandel International Ltd as on 13 February 2026?
The current stock price of Coromandel International Ltd as on 13 February 2026 is ₹2,270.
What is the High / Low of Coromandel International Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Coromandel International Ltd stocks is ₹2,720/1,590.
What is the Stock P/E of Coromandel International Ltd?
The Stock P/E of Coromandel International Ltd is 31.6.
What is the Book Value of Coromandel International Ltd?
The Book Value of Coromandel International Ltd is 413.
What is the Dividend Yield of Coromandel International Ltd?
The Dividend Yield of Coromandel International Ltd is 0.53 %.
What is the ROCE of Coromandel International Ltd?
The ROCE of Coromandel International Ltd is 23.2 %.
What is the ROE of Coromandel International Ltd?
The ROE of Coromandel International Ltd is 16.9 %.
What is the Face Value of Coromandel International Ltd?
The Face Value of Coromandel International Ltd is 1.00.